Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of A Novel Enteral Feeding System: Prospective Study.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with Gastrostomy (G) tube or Jejunostomy (J) tubes~* Participant must require enteral tube feeding every day, as determined at the time of study enrolment~* Participant must use commercially available enteral formula with standard enteral feeding system(s) (gravity bag, bolus, pump or combination(s)), for some or all of their tube feeds, for daytime or day and night-time feeding~* Participant must be EN dependent i.e., 500 ml minimum daily feed intake from EN~* Participants must be able to swap from current system to Mobility+ for a minimum of two daily feeds per day for duration of study (Study days 1 -14)~* Participant must be \>= 18 to reflect the subset of the intended use population being evaluated~* Participant must be willing to participate in the study and provide consent).~* Participants must have been on an enteral feeding regime for a minimum of 10 weeks~* Participants clinical functional capacity is adequate as determined by operator clinical judgement, to enable them to participate fully in the study~* Participants are suitable candidates for using Mobility+ as determined by operator clinical judgement on participant enteral feeding needs (as per prescription) and alignment with Mobility+ Flow Rate Guide~Exclusion Criteria:~* Participants who do not use commercially available enteral formula for some or all their formula needs~* Participants unable/unwilling to provide consent~* Participants whose enteral feeding needs do not match the offering of the Mobility+, as determined by operator clinical judgement~* Participants who have inadequate clinical functional capacity, as determined by operator clinical judgement to participate fully in the study e.g. neuromuscular or neurodegenerative disorders, or developmental delay~* Participants with very limited mobility, as determined by operator clinical opinion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mobility+ Arm (Type: EXPERIMENTAL): Adult patients using Mobility+ novel enteral feeding system for nutritional intake.

Based on this trial design, predict the completion outcome and termination type (if applicable).